2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
CNS
1
Conditions
Multiple Myeloma
121
Neoplasms, Plasma Cell
36
Neoplasms
14
Carcinoma, Hepatocellular
13
Recurrence
12
Brain Neoplasms
12
Prostatic Neoplasms
11
Melanoma
11
Central Nervous System Neoplasms
11
Glioblastoma
10
Leukemia
9
Carcinoma, Non-Small-Cell Lung
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Gliosarcoma
8
Waldenstrom Macroglobulinemia
7
Sarcoma
7
Lung Neoplasms
7
Glioma
7
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Liver Neoplasms
6
Myeloproliferative Disorders
5
Myelodysplastic Syndromes
5
Lymphoma, Mantle-Cell
5
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma
5
Kidney Neoplasms
5
Immunoglobulin Light-chain Amyloidosis
5
Myelodysplastic-Myeloproliferative Diseases
4
Lymphoma, Follicular
4
Interventions
Cyclophosphamide
25
Temozolomide
22
Vincristine
18
Irinotecan
18
Doxorubicin
13
Topotecan
10
Melphalan
10
Etoposide
10
Ifosfamide
8
Busulfan
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
Granulocyte Colony-Stimulating Factor
7
Filgrastim
6
regorafenib
5
fludarabine
5
X-Rays
5
Specimen Handling
5
Sirolimus
5
Radiotherapy
5
Gemcitabine
5
Drug Therapy
5
pegfilgrastim
4
palbociclib
4
liposomal doxorubicin
4
irinotecan sucrosofate
4
ganitumab
4
fludarabine phosphate
4
Trabectedin
4
Phantoms, Imaging
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Thalidomide
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled